A urinary tract infection (UTI) is a bacterial infection that affects your bladder, urethra, or kidneys. It occurs when bacteria—most commonly E. coli—enter and invade your bladder. Common ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

We are thrilled to welcome Chris to our team at this exciting time for Design, as we advance our portfolio of GeneTAC ® small molecules toward key clinical milestones,” said Pratik Shah, Ph.D., ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

As of Tuesday, April 15, iTeos Therapeutics, Inc.’s ITOS share price has surged by 7.59%, which has investors questioning if ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

Nektar Therapeutics’s NKTR share price has surged by 18.21%, which has investors questioning if this is right time to sell.

Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in ...

Financing of Merida Biosciences was backed by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, with ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, Ratings reports. One equities ...